Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SIGY

Sigyn Therapeutics (QB) (SIGY)

Sigyn Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:SIGY
DateTimeSourceHeadlineSymbolCompany
01/31/20243:20PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
01/30/20243:23PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
01/11/20242:25PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
01/08/20241:34PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
12/12/20231:48PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
10/26/20232:23PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
10/04/20234:10PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
09/19/20232:56PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
08/14/20232:35PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:SIGYSigyn Therapeutics Inc (QB)
07/07/202310:15AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
06/08/20231:38PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
05/17/20236:15AMInvestorsHub NewsWireSigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep™ Trademark ApplicationUSOTC:SIGYSigyn Therapeutics Inc (QB)
05/15/20234:35PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
05/10/20234:27PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
03/31/20239:06AMInvestorsHub NewsWireSigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-KUSOTC:SIGYSigyn Therapeutics Inc (QB)
03/31/20235:19AMEdgar (US Regulatory)Annual Report (10-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
02/28/20232:19PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
12/23/20222:52PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
11/14/20222:51PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
09/14/202211:37AMInvestorsHub NewsWireSigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease PatientsUSOTC:SIGYSigyn Therapeutics Inc (QB)
08/30/20225:09AMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
08/15/20225:32AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
08/03/20226:07AMInvestorsHub NewsWireSigyn Therapeutics to Commence Trading on the OTCQB® Venture ExchangeUSOTC:SIGYSigyn Therapeutics Inc (QB)
06/23/20225:02AMEdgar (US Regulatory)Securities Registration Statement (s-1)USOTC:SIGYSigyn Therapeutics Inc (QB)
05/23/20224:00AMTipRanksAnalysts Are Bullish on These Healthcare Stocks: Sigyn Therapeutics (SIGY)USOTC:SIGYSigyn Therapeutics Inc (QB)
03/21/20224:29PMEdgar (US Regulatory)Annual Report (10-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
03/01/20224:28PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
02/04/20229:48AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
12/17/20217:48AMInvestorsHub NewsWireSigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapies Were Not Drugs or VaccinesUSOTC:SIGYSigyn Therapeutics Inc (QB)
11/12/20213:49PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:SIGY